Medical Device Market Access in ASEAN: Malaysia, Singapore, and Vietnam Compared

Medical device market access in ASEAN has become a strategic priority for international manufacturers seeking sustainable growth in Southeast Asia. Across the region, rising healthcare demand, increased public investment, and steadily maturing regulatory frameworks are converging to create attractive conditions for foreign market entry.

Within this broader ASEAN landscape, Malaysia, Singapore, and Vietnam emerge as three complementary entry points. Each country offers distinct regulatory and commercial advantages, yet all remain broadly aligned with ASEAN harmonization principles. This balance makes them particularly suitable for manufacturers pursuing a phased expansion or a coordinated multi-country registration strategy.

Continue reading to understand the distinct benefits and regulatory pathways of these three strategic ASEAN entry points, or get in touch with Cisema for support with medical device registration, license holding, and ASEAN market entry planning.

Malaysia: Strong Medical Tourism and Strategic Regulatory Advantage

Malaysia has been ranked the number one destination for medical tourism globally, reflecting its strong healthcare infrastructure and international trust. According to Nomad Capitalist, Malaysia ranks #1 in the world for medical tourism.

For manufacturers, this translates to a clear market opportunity. For medical device manufacturers, this reputation directly translates into commercial opportunity, particularly for products used in private hospitals and specialized care settings.

Singapore: Medical Device Approval With Regional Regulatory Influence

Singapore provides one of the most mature and transparent regulatory environments for medical devices in Asia. Its regulatory system is frequently viewed as a regional benchmark, and approvals obtained in Singapore are often leveraged to support registrations in neighboring markets.

Singapore’s healthcare reputation is further reinforced by its second-place global ranking in medical tourism. Medical device registration in Singapore typically applies to Class B through Class D devices, with approval timelines ranging from approximately 5 to 12 months depending on the chosen evaluation route. While timelines may be longer than in other ASEAN markets, Singapore medical device approval offers high regulatory credibility and strategic value for regional expansion.

Vietnam: Fast Registration Timelines and Market Growth

With a population exceeding 100 million, Vietnam is among the fastest-growing medical device markets in Asia. The market is projected to reach US$1.77 billion in 2025 and expand to US$2.47 billion by 2029 (Statista), driven by rising healthcare expenditure and significant infrastructure investment.

Government initiatives, including the National Strategy for Developing Vietnam’s Pharmaceutical Industry and the Grassroots Healthcare Network Development Plan, actively encourage foreign participation.From a regulatory standpoint, Vietnam stands out for speed. Class A and Class B medical device registration in Vietnam can be completed within as little as 14 calendar days, offering some of the fastest approval timelines in Southeast Asia.

Comparing Medical Device Markets In Malaysia, Singapore, And Vietnam

With these individual country profiles in mind, comparing market scale, timelines, and economic context highlights how the 3 markets complement one another within a regional expansion plan.

Market Size And Registration Timeline Comparison

Together, these figures illustrate how manufacturers can balance speed, scale, and regulatory signaling by sequencing or combining these markets.

Medical Device Application and Licensing Fee Comparison

Cost is a critical factor when planning medical device registration in multiple ASEAN countries, particularly for portfolio-based or regional launches.

*Note: Vietnam registration fees may vary slightly due to local administrative adjustments or temporary fee waivers.

Coordinating Medical Device Registration Across Multiple ASEAN Markets

After comparing the strategic roles of Malaysia, Singapore, and Vietnam, the next practical question for manufacturers is how to coordinate regulatory control across multiple jurisdictions simultaneously.

Although ASEAN regulatory frameworks are gradually aligning through harmonization initiatives, each country still maintains its own submission procedures, license structures, and post-market obligations. Managing these differences internally can quickly become complex, particularly for manufacturers launching multiple devices or working with several distributors

For this reason, many international companies adopt a centralized regulatory management model, in which an independent local representative maintains regulatory licenses while manufacturers retain commercial flexibility.

Cisema provides this structure across Malaysia, Singapore, and Vietnam by acting as an independent license holder and authorized regulatory representative:

• Malaysia: Licensed local representation and close coordination with the Medical Device Authority ensure efficient management of new registrations and legacy device transfers.
• Singapore: Direct management of Health Sciences Authority registrations enables streamlined regulator communication, precise license control, and efficient post-approval change management.
• Vietnam: Local regulatory expertise supports compliance with evolving regulations while assisting manufacturers with licensing obligations, post-market requirements, and distributor coordination

This approach allows manufacturers to maintain full authority over importer and distributor selection across all three ASEAN markets while avoiding distributor-controlled registrations that can limit long-term flexibility.

Core ASEAN Medical Device Regulatory Services

Building on this regulatory management model, Cisema provides a set of services designed to support manufacturers throughout the medical device lifecycle across Southeast Asia.

These services ensure that companies entering Malaysia, Singapore, and Vietnam can maintain regulatory continuity while scaling their regional presence.

Core services include:

• License holding and authorized representation
• Country-specific regulatory strategy and classification advisory
• Product registration support, including ASEAN CSDT and local formatting
• Regulatory intelligence and policy tracking
• Post-approval change management and post-market surveillance
• Feasibility assessments for future ASEAN market entry

Together, these capabilities allow manufacturers to pursue multi-country market entry strategies with greater speed, flexibility, and regulatory control, while ensuring that compliance obligations remain consistently managed across jurisdictions.

Final Thoughts

Medical device registration in ASEAN is rarely a linear process. Malaysia, Singapore, and Vietnam each play a different strategic role, offering varying balances of speed, regulatory rigor, and market scale. For international manufacturers, the real challenge lies in coordinating these differences into a coherent regional strategy — one that preserves regulatory control, supports future expansion, and adapts as commercial priorities evolve.

That is where experienced regulatory stewardship becomes essential. Cisema works alongside manufacturers as a long-term regulatory partner, providing the local presence, cross-border coordination, and technical depth needed to manage registrations, licenses, and post-market obligations across multiple ASEAN markets. Whether you are assessing feasibility or preparing submissions, our team supports each phase of the device lifecycle with continuity and clarity.

Further Information

If you are a medical device manufacturer seeking clarity on registration timelines, approval pathways, or regulatory costs in Malaysia, Singapore, or Vietnam, please contact Cisema or explore our country-specific medical device service pages:

• Medical Device Registration in Malaysia
• Medical Device Registration in Singapore
• Medical Device Registration in Vietnam

About the Author: Shouzheng Tan

Shouzheng Tan is Vice President of Southeast Asia at Cisema, based in Penang, Malaysia. He brings more than a decade of experience in the medical device industry, specializing in regulatory registration and market access across Southeast Asia. In his role, he works closely with overseas manufacturers to develop and implement effective regulatory strategies for medical devices throughout the region, including key markets such as Malaysia. His expertise is complemented by working knowledge of quality management systems, allowing him to support clients across both regulatory and compliance requirements.